| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology, New York Medical College, Valhalla, NY, USA
* To whom correspondence should be addressed. E-mail: fan_zhang{at}nymc.edu.
Pulmonary intralobar arteries express heme oxygenase (HO)-1 and -2 and release CO during incubation in Krebs' buffer. Acute hypoxia elicits isometric tension development (0.77±0.06 mN/mm) in pulmonary vascular rings treated with chromium mesoporphyrin (15 µmol/L; CrMP), an inhibitor of HO-dependent CO synthesis, but has no effect in untreated vessels. Acute hypoxia also induces contraction of pulmonary vessels taken from rats injected with HO-2 antisense oligodeoxynucleotides, which decrease pulmonary HO-2 vascular expression and CO release. Hypoxia-induced contraction of vessels treated with CrMP is attenuated (P<0.05) by endothelium removal, by CO (1-100 µmol/L) in the bathing buffer, and by endothelin-1 (ET-1) receptor blockade with L754,142 (10 µmol/L). CrMP increases ET-1 levels in pulmonary intralobar arteries, particularly during incubation in hypooxygenated media. CrMP also causes a leftward shift in the concentration-response curve to ET-1 which is offset by exogenous CO. In anesthetized rats, pretreatment with CrMP (40 µmol/kg, IV) intensifies the elevation of pulmonary artery pressure elicited by breathing a hypoxic gas mixture. However, acute hypoxia does not elicit augmentation of pulmonary arterial pressure in rats pretreated concurrently with CrMP and the ET-1 receptor antagonist L745142 (15 mg/kg, IV). These data suggest that a product of HO activity, most likely CO, inhibits hypoxia-induced pulmonary vasoconstriction by reducing ET-1 vascular levels and sensitivity.
This article has been cited by other articles:
|
|
 |
|
  N. G. Abraham, J. Cao, D. Sacerdoti, X. Li, and G. Drummond Heme oxygenase: the key to renal function regulation Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1137 - F1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ahmad, X. Zhao, M. R. Kelly, S. Kandhi, O. Perez, N. G. Abraham, and M. S. Wolin Heme oxygenase-1 induction modulates hypoxic pulmonary vasoconstriction through upregulation of ecSOD Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1453 - H1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Peterson, D. H. Kim, M. Li, V. Positano, L. Vanella, L. F. Rodella, F. Piccolomini, N. Puri, A. Gastaldelli, C. Kusmic, et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice J. Lipid Res., July 1, 2009; 50(7): 1293 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Lin, D. A. Hessinger, W. J. Pearce, and L. D. Longo Modulation of BK channel calcium affinity by differential phosphorylation in developing ovine basilar artery myocytes Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H732 - H740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Turkseven, A. Kruger, C. J. Mingone, P. Kaminski, M. Inaba, L. F. Rodella, S. Ikehara, M. S. Wolin, and N. G. Abraham Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H701 - H707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Hartsfield, I. F. McMurtry, D. D. Ivy, K. G. Morris, S. Vidmar, D. M. Rodman, and K. A. Fagan Cardioprotective and vasomotor effects of HO activity during acute and chronic hypoxia Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2009 - H2015. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
